- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
DXCM
MEX
Week ended 31 Jul 2026
Weekly Investor Report
DexCom, Inc. · Healthcare · Medical Devices
Latest close
1,430 MXN
15.8%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 15.7% above the Trend Line and sits at 70.9% of its 52-week range. The latest completed week returned 15.8%, after a 14.6% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
54
out of 100
Latest Close
1,430 MXN
31 Jul 2026
1W Return
15.8%
latest completed week
4W Return
14.6%
short-term follow-through
12W Return
18.2%
quarterly tape
Trend Breadth
7.7%
4 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 21.72% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
15.8%
Latest completed week; four-week move 14.6%.
Indicator stack
8/77
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 21.72%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 15.7% above the Trend Line and sits at 70.9% of its 52-week range. The latest completed week returned 15.8%, after a 14.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4212-week average 0.28
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.42Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 14.6% over four weeks, 18.2% over 12 weeks, and -9.4% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year4
Trend breadth7.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.09Latest activity-pressure read.
Pressure change89.9%Four-week change in activity pressure.
Leadership10.87Latest relative-leadership reading.
RS change269.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.6%Distance below the 52-week high.
13-week volatility7.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher6 of 266 weeks finished lower.
Best week+16.6%Week of 29 May.
Worst week-12.0%Week of 15 May.
Latest week+15.8%Week of 31 Jul.
Shape of recent returns
Strong gains3
Modest gains3
Flat weeks14
Modest losses2
Sharp losses4
Recent vol7.9%13-week weekly-return volatility.
Base vol5.2%52-week weekly-return volatility.
Up/down split16/17Count of positive and negative weeks in the 52-week window.
Average skew4.8% / -4.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorMX Healthcare
4-week rank8 / 78
Group average-1.3%
Trend breadth28.2%
Trend28.2%active weekly trend signals
MD62.8%positive activity pressure
RS35.9%positive relative leadership
Four-week leaders
IndustryMX Medical Devices
4-week rank1 / 9
Group average4.4%
Trend breadth11.1%
Trend11.1%active weekly trend signals
MD55.6%positive activity pressure
RS11.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape46/100
Trend, activity pressure, participation, and risk combine to a 46/100 tape read.
Indicator analysis34/100Latest 12-week confirmation: trend 1/12, activity pressure 7/12, relative leadership 2/12.
Activity pressure 0.42; No reversal markers Next-Week ExpectancyNegative 21.72%Next-week expectancy is negative with a 21.72% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 1,430 MXN | 15.8% | 1,236 MXN | 1,569 MXN | 1.09 | 10.87 | 697 | On |
| 24 Jul 2026 | 1,235 MXN | -9.1% | 1,228 MXN | 1,573 MXN | 0.97 | -4.06 | 160 | Off |
| 17 Jul 2026 | 1,358 MXN | 9.1% | 1,227 MXN | 1,579 MXN | 1.00 | 4.17 | 11.5K | Off |
| 10 Jul 2026 | 1,245 MXN | -0.2% | 1,222 MXN | 1,585 MXN | 0.70 | -5.02 | 10 | Off |
| 3 Jul 2026 | 1,248 MXN | 0.5% | 1,222 MXN | 1,592 MXN | 0.57 | -6.43 | 310 | Off |
| 26 Jun 2026 | 1,242 MXN | 0.0% | 1,219 MXN | 1,598 MXN | 0.41 | -7.91 | 0 | Off |
| 19 Jun 2026 | 1,242 MXN | 0.0% | 1,217 MXN | 1,604 MXN | 0.30 | -9.37 | 0 | Off |
| 12 Jun 2026 | 1,242 MXN | 0.0% | 1,212 MXN | 1,610 MXN | -0.06 | -10.54 | 0 | Off |
| 5 Jun 2026 | 1,242 MXN | 0.0% | 1,207 MXN | 1,617 MXN | -0.37 | -8.90 | 7 | Off |
| 29 May 2026 | 1,242 MXN | 16.6% | 1,202 MXN | 1,623 MXN | -0.52 | -12.90 | 2.5K | Off |
| 22 May 2026 | 1,065 MXN | 0.0% | 1,198 MXN | 1,627 MXN | -0.69 | -25.73 | 0 | Off |
| 15 May 2026 | 1,065 MXN | -12.0% | 1,203 MXN | 1,634 MXN | -0.47 | -26.16 | 400 | Off |
| 8 May 2026 | 1,210 MXN | 0.0% | 1,208 MXN | 1,641 MXN | -0.24 | -19.32 | 0 | On |
| 1 May 2026 | 1,210 MXN | 0.0% | 1,209 MXN | 1,647 MXN | -0.14 | -17.26 | 0 | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.